Sperm Check
SpermCheck is a privately held, FDA-cleared at-home diagnostics company selling lateral flow sperm count test kits (Fertility and Vasectomy SKUs) directly to consumers via e-commerce and major US pharmacy retail, serving men and couples evaluating fertility or post-vasectomy sterility.
- Company typePrivate
- Founded2012
- HeadquartersCharlottesville, United States
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Sperm Check does
SpermCheck is a privately held consumer diagnostics company founded in 2012 and headquartered in Charlottesville, Virginia at the UVA Research Park, originally commercialized from ContraVac, a University of Virginia startup founded by Dr. John Herr. The company develops, manufactures, and sells FDA-cleared at-home lateral flow immunoassay test kits that detect the SP-10 sperm-specific protein to provide a sperm count indication in minutes, marketed under the SpermCheck® Fertility and SpermCheck® Vasectomy product lines with reported 98% accuracy.
The company operates a direct-to-consumer and omnichannel retail model. Its two core SKUs — the SpermCheck Fertility Home Sperm Test ($49 per unit) and the SpermCheck Vasectomy Home Follow-Up Test ($79 per 2-pack, with a subscription option offering up to 25% savings) — are sold via the company's e-commerce site and distributed through major US pharmacy chains (CVS, Walgreens, Rite Aid) alongside international retail in the UK, Canada, Australia/New Zealand, and China. Both tests are FDA-cleared, FSA/HSA eligible, and positioned as private, low-cost alternatives to clinical semen analysis.
SpermCheck serves two primary consumer segments: men and couples trying to conceive who want a preliminary at-home fertility screen, and post-vasectomy men monitoring sterility. The company has cumulatively sold over one million tests and reports more than 5,000 verified five-star reviews, supported by content marketing, TV media placements, and an affiliate/influencer program. Operational and manufacturing infrastructure is anchored through an affiliation with DDC (DNA Diagnostics Center), which appears as the parent/manufacturing entity on the company's website.
Sperm Check firmographics
Firmographics- Name
- Sperm Check
- Legal name
- SpermCheck
- Website
- https://spermcheck.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SpermCheck is a privately held, FDA-cleared at-home diagnostics company selling lateral flow sperm count test kits (Fertility and Vasectomy SKUs) directly to consumers via e-commerce and major US pharmacy retail, serving men and couples evaluating fertility or post-vasectomy sterility.
- Ownership category
- akta.pro rank
Sperm Check industry classification
Industry- Product category
- At-Home Diagnostic Tests
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection) (HLAHAOAF)
- akta.pro secondary industry
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Sperm Check is headquartered
LocationHeadquarters
- HQ city
- Charlottesville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Sperm Check business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Revenue model
- Direct Product Sales: SpermCheck generates revenue through one-time purchase of at-home sperm count test kits sold directly to consumers via e-commerce and retail pharmacies. The company also offers subscription plans with up to 25% savings for recurring purchases.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | SpermCheck Fertility Test - One-time purchase |
| One time/ perpetual license | Pay-as-you-go | SpermCheck Vasectomy Test (2-Pack) - One-time purchase |
| Subscription | Monthly | SpermCheck Vasectomy Test - Subscription |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Sperm Check product offering
Product offeringCore offering
SpermCheck sells FDA-cleared at-home sperm count test kits that detect SP-10 protein in semen samples to determine sperm count levels with 98% accuracy. The company offers two core products: the SpermCheck Fertility Home Sperm Test for men and couples trying to conceive, and the SpermCheck Vasectomy Home Follow-Up Test for post-vasectomy sterility confirmation. Both deliver results within minutes in the privacy of home without requiring a prescription or clinical visit.
Product overview
SpermCheck is the original at-home sperm count testing company offering two FDA-cleared diagnostic test kits: the SpermCheck® Fertility Home Sperm Test (for men checking fertility status when trying to conceive) and the SpermCheck Vasectomy Home Follow-Up Test (for men confirming sterility after vasectomy). Both tests are lateral flow immunoassay devices that detect SP-10 protein levels with 98% accuracy, providing results in minutes from the privacy of home. The company also offers subscription plans for the Vasectomy test with savings up to 25%.
Differentiator
Problem solved
Functional benefit
Products and services
- SpermCheck Fertility Home Sperm Test An FDA-cleared at-home sperm count test for men to check fertility status. Detects SP-10 protein levels with 98% accuracy and provides results within minutes for couples trying to conceive. Sold at $49 per unit.
- SpermCheck Vasectomy Home Follow-Up Test (2-Pack) An FDA-cleared at-home test kit for post-vasectomy men to confirm their semen is sperm-free. The 2-pack allows testing at two different intervals (recommended at 60 and 90 days post-procedure). Sold at $79 for 2 tests, with subscription option offering up to 25% savings.
Quantifiable outcome
- 98% accuracy in detecting sperm count levels
- +2 more outcomes
Companies that use Sperm Check
Customer profileSegments3 records
Ideal customer profiles3 records
Sperm Check technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sperm Check partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, major and minor.
- DDC (Diagnostic Testing Corporation)coreDDC appears in the footer as the parent/parent company for SpermCheck, providing manufacturing and regulatory support for the diagnostic test products.
- CVS PharmacymajorSpermCheck products are sold in CVS retail stores nationwide as part of major pharmacy chain distribution expansion starting October 2014.
- WalgreensmajorSpermCheck products became available at Walgreens as part of the 2014 pharmacy store expansion alongside CVS and RiteAid.
- Rite AidmajorSpermCheck announced major expansion into Rite Aid stores nationwide in August 2014, making products available at over 4,600 locations.
- Health CanadamajorHealth Canada cleared SpermCheck Fertility for over-the-counter sale in Canada in October 2013, enabling international market expansion.
- Sonia Ribas (Fertility Coach)minorSonia Ribas, a certified fertility coach with degrees from ESADE Business School and HEC Paris, provides insights and content for SpermCheck marketing materials.
- UVA Research Park / ContraVaccoreSpermCheck was developed by ContraVac, a UVA startup based at the UVA Research Park, with Dr. John Herr as founder. The company originated from university research.
- Center for Innovative Technology (CIT)minorVirginia-based CIT (now Virginia Innovation Partnership Corporation) supported the technology transfer and commercialization of the SpermCheck product.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Sperm Check competitors and assessment
Company assessmentBroad incumbents
- First Response (Church & Dwight): Category-leading OTC pregnancy and ovulation test brand owned by Church & Dwight. Shares the at-home rapid diagnostic retail channel with SpermCheck and represents the broader consumer fertility testing incumbent SpermCheck competes against for shelf space.
- Clearblue: Global OTC pregnancy and ovulation testing brand (Procter & Gamble / Swiss Precision Diagnostics). Competes for the same at-home reproductive-health self-testing shopper across pharmacy shelves and DTC channels where SpermCheck is sold.
- Labcorp: National clinical laboratory network that performs physician-ordered semen analysis, the $100–$1,000+ clinical alternative SpermCheck explicitly undercuts. Represents both a competitive incumbent and a potential channel/referral partner.
- Quest Diagnostics: Large US clinical lab offering physician-ordered semen analysis and male fertility panels. Like Labcorp, sets the price-and-process benchmark that SpermCheck positions against for at-home pre-screening.
Direct peers
- Dadi: Men's fertility company providing at-home sperm collection and reporting kits with optional storage. Competes with SpermCheck for the at-home male fertility testing entry point, adding a storage/subscription layer.
- ExSeed Health: UK-based direct-to-consumer male fertility testing company offering at-home sperm analysis kits with smartphone-based video readouts and a coaching layer. Competes head-to-head with SpermCheck in the UK and increasingly in the US for at-home sperm testing wallet share.
- YO Home Sperm Test (Medical Electronic Systems): Direct competitor selling an FDA-cleared at-home sperm test that pairs a cassette with a smartphone app to assess motility and count. Closest like-for-like rival to SpermCheck's at-home male fertility proposition, differentiated by digital video readouts.
- Legacy: Men's fertility company offering at-home sperm analysis and cryopreservation. Shares SpermCheck's at-home self-collection screening step before any clinical handoff, competing for the same male-factor-infertility aware consumer.
- Fellow Health: Sandstone Diagnostics spinoff (formerly known as Sandstone) selling at-home male fertility and testosterone test kits. Overlaps directly with SpermCheck's at-home diagnostics value proposition and distribution model.
- Mojo: UK-based men's fertility platform offering at-home sperm testing with clinical-grade analysis and fertility specialist access. Comparable to SpermCheck's at-home offering, with a stronger digital coaching and clinical referral layer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Sperm Check social profiles
Digital presenceSperm Check compliance and trust
Trust signalCompliance1 record
Sperm Check financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sperm Check leadership team
Management profileNumber of profiles
Profiles1 record
Sperm Check funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sperm Check M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sperm Check
What does Sperm Check do?
SpermCheck sells FDA-cleared at-home sperm count test kits that detect SP-10 protein in semen samples to determine sperm count levels with 98% accuracy. The company offers two core products: the SpermCheck Fertility Home Sperm Test for men and couples trying to conceive, and the SpermCheck Vasectomy Home Follow-Up Test for post-vasectomy sterility confirmation. Both deliver results within minutes in the privacy of home without requiring a prescription or clinical visit.
Is Sperm Check a public or private company?
Sperm Check is a private company. It is classified as corporate owned and is currently operating.
When was Sperm Check founded?
Sperm Check was founded in 2012. It employs 1 to 10 people.
Where is Sperm Check based?
Sperm Check is headquartered in Charlottesville, United States, in the North America region.
How does Sperm Check make money?
One revenue line is on record: direct Product Sales.
Who are Sperm Check's main competitors?
Broad incumbents on record are First Response (Church & Dwight), Clearblue, Labcorp and Quest Diagnostics. Direct peers are Dadi, ExSeed Health, YO Home Sperm Test (Medical Electronic Systems), Legacy, Fellow Health and Mojo.
Does Sperm Check have an API?
No public API is recorded for Sperm Check.
What industry is Sperm Check in?
Sperm Check's product category is At-Home Diagnostic Tests. Its primary akta.pro industry code is HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection), with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 325413 and its SIC code is 2835.